Pirepemat (fumarate)
Pirepemat (IRL752) fumarate is a corticalpreferring catecholamine- and cognition-promoting agent. Pirepemat fumarate is used for the study of Parkinson's disease[1][2].
Product Specifications
CAS Number
[2251806-70-7]
Product Name Alternative
IRL752 (fumarate)
UNSPSC
12352005
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pirepemat-fumarate.html
Purity
98.26
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CO[C@]1(C(C=CC=C2F)=C2F)CCNC1.O=C(O)/C=C/C(O)=O
Molecular Formula
C15H17F2NO5
Molecular Weight
329.30
References & Citations
[1]Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson's Disease.|[2]S Hjorth, et al. (3 S) -3- (2,3-difluorophenyl) -3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent. J Pharmacol Exp Ther. 2020 Sep;374 (3) :404-419.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
